OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Publication Date
Release Date
2020
(16)
2022
(2)
2021
(2)
2024
(1)
2015
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Not available
S-EPMC4374346
|
biostudies-literature
Cite
Genomic footprints of activated telomere maintenance mechanisms in cancer.
Not available
S-EPMC7002710
|
biostudies-literature
Cite
Inferring structural variant cancer cell fraction.
Not available
S-EPMC7002525
|
biostudies-literature
Cite
Combined burden and functional impact tests for cancer driver discovery using DriverPower.
Not available
S-EPMC7002750
|
biostudies-literature
Cite
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis.
Not available
S-EPMC7002399
|
biostudies-literature
Cite
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer.
Not available
S-EPMC7058537
|
biostudies-literature
Cite
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations.
Not available
S-EPMC7002524
|
biostudies-literature
Cite
Pathway and network analysis of more than 2500 whole cancer genomes.
Not available
S-EPMC7002574
|
biostudies-literature
Cite
Integrative pathway enrichment analysis of multivariate omics data.
Not available
S-EPMC7002665
|
biostudies-literature
Cite
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Not available
S-EPMC7058534
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets